Endoüroloji Bülteni

Endourology Bulletin is a scientific, referred, open access publication of the Eurasian Urooncological Association. Society is a non-profit organization, and it aims to increase the standards in the field of urology, including the education of academicians, professionals, and the public. The society also aims to create or make contributions to the development of technical, scientific, and social facilities. For this purpose, it also cooperates with any related institutions, organizations, foundations, and societies from the national and international areas.

The Eurasian Urooncological Association covers the journal's financial expenses. The journal is published three times a year- in January, May, and September, respectively, and the journal's language is Turkish and English.

The purpose of the Endourology Bulletin is to contribute to the literature by publishing urological manuscripts such as scientific articles, reviews, letters to the editor, case reports, reports of surgical techniques, surgical history, ethics, surgical education, and articles of forensic medicine.
The target group of the journal consists of academicians working in the field of urology, urologists, residents of urology, and all other fields of expertise and practitioners interested in urology.
Urology specialists, medical specialty fellows, and other specialists interested in the field of urology are the journal's target audience.

In the Bulletin of Endourology, high scientific quality research articles, rare case reports, letters to the editor, reviews of the current literature prepared by experts, video articles containing surgical techniques, and current and future practice reviews prepared by world-renowned people in the field of Endourology, comments are posted.
The Bulletin of Endourology is a peer-reviewed journal that accepts original articles, case reports, and reviews on urology and urology-related topics for publication.

The Endourology Bulletin is the publication of the Endourology Society. The journal is published three times a year in January, May and September.

Endourology Bulletin is an international, scientific, open-access, online journal with independent, impartial, and double-blind evaluation principles.
The languages of the Endourology Bulletin are Turkish and English.
All published content is available for free at the link.

All manuscripts submitted to the journal should be submitted through the online application system available at www.dergipark.org.tr/en/pub/endouroloji.
Instructions for authors, including technical information and required forms, can be found at the journal's website https://dergipark.org.tr/tr/pub/endouroloji/page/16266.
Editorial and publication processes of the journal are shaped following the guidelines of international organizations such as the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE). The journal conforms with Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice). The journal publishes in accordance with the World Medical Association (WMA) Declaration of Helsinki on Ethical Principles for medical research involving human subjects.

The Endourology Society has national and international copyright to all content published in the journal.

The journal is published online.

The statements and/or opinions indicated in the articles published at the journal reflect the author's views, not the opinions of the editors, editorial board and/or the Endourology Society. Editors and publishers do not accept any responsibility for such materials.
Submitting articles to the journal, processing, and publishing them is free of charge. No fee is required for submitting articles, evaluating, processing, or publishing the authors.

Authors' credentials and e-mail addresses are not used for other purposes.
The submitted articles should be previously unpublished and should not be under consideration by any other journal.
If the whole or a part of the submitted articles are presented in any congress, this should be noted in the submitted article.
The journal's Editorial Board handles all appeal and complaint cases within the scope of Committee on Publication Ethics (COPE) guidelines. In such cases, authors should contact the editorial office directly regarding their appeals and complaints. When needed, an ombudsperson may be assigned to resolve cases that cannot be resolved internally. The Editor in Chief is the final authority in the decision-making process for all appeals and complaints.
The editorial and publication processes of the journal are shaped following the guidelines of the International Council of Medical Journal Editors (ICMJE).
The journal conforms to the Principles of Transparency and Best Practice in Scholarly Publishing (DOAJ).
Originality, high scientific quality, and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. Manuscripts presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.
An approval of research protocols by the Ethics Committee following international agreements (World Medical Association Declaration of Helsinki "Ethical Principles for Medical Research Involving Human Subjects" ) is required for experimental, clinical, and drug studies and some case reports.
For all research that requires ethics committee permission ethics committee approval should be obtained, this approval should be stated and documented in the article.
In studies that require ethics committee permission, information about the permission (name of the committee, date, and number) can be found in the method section, as well as on one of the first/last pages of the article; In case reports, information about signing the informed consent/consent form should be included in the article.
• For manuscripts concerning experimental research on humans, a statement should be included that shows that written informed consent of patients and volunteers was obtained following a detailed explanation of the procedures they may undergo.
• For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly.
• Information on patient consent, the name of the ethics committee, and the ethics committee approval number should also be stated in the Materials and Methods section of the manuscript.
• It is the authors' responsibility to protect the patients' anonymity carefully. For photographs that may reveal the identity of the patients, releases signed by the patient or their legal representative should be enclosed.
All submissions are screened by a similarity detection software (iThenticate), and the limitation without similarity is 20%.
When submitting a manuscript to Endourology Bulletin, authors accept to assign the copyright of their manuscript to the journal. If rejected for publication, the manuscript's copyright will be assigned back to the authors.
Endourology Bulletin requires each submission to be accompanied by a Copyright Agreement&Acknowledgement of Authorship Form .
Every paper published in Endourology Bulletin is licensed under an Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).
Authors must obtain permission from the copyright holder when using previously published content, including figures, tables, or any other material in both print and electronic formats.
In this regard, legal, financial, and criminal liabilities belong to the author (s).
Statements or opinions expressed in the manuscripts published in Endourology Bulletin reflect the author's views (s) and not the opinions of the editors, the editorial board, or the publisher; the editors, the editorial board, and the publisher disclaim any responsibility or liability for such materials. The final responsibility regarding the published content rests with the authors.

MANUSCRIPT PREPARATION

Manuscripts can only be submitted through the journal's online manuscript submission and evaluation system, available at https://dergipark.org.tr/en/pub/endouroloji. Manuscripts submitted via any other medium will not be evaluated.

Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office staff will ensure that the manuscript has been prepared and submitted following the journal's guidelines.

Submissions that do not conform to the journal's guidelines will be returned to the submitting author with technical correction requests.

Corrections may be done without changing the main text.

The editor reserves the right to reject manuscripts that do not comply with the aforementioned requirements.

Authors are required to submit the following:

• Copyright Agreement&Acknowledgement of Authorship Form,
• Informed Consent Form
• ICMJE Disclosure of Interest Form
• Title Page (including Title of Manuscript, Running title, author (s) 's name, title, and institution, corresponding author's contact information, Name of the organization supporting the research)
• Main document (All articles should have an abstract before the main text).
• Figures (Jpeg format)
• Tables (max 6 tables)

Preparation of the Main Document

Original articles should have a structured abstract. (Objective, Material and Methods, Results, Conclusion).
For case reports, the structured abstract is not used. Limit the abstract to 300 words.
References, tables, and citations should not be used in an abstract.
Authors must include relevant keywords (3-5) on the line following the end of the abstract.
The Turkish title, abstracts, and Turkish keywords are not required for the international authors. The editorial office will provide these.

All acronyms and abbreviations used in the manuscript should be defined first, both in the abstract and in the main text. The abbreviation should be provided in parentheses following the definition.
When a drug, product, hardware, or software program is mentioned within the main text, product information, including the name of the product, the producer of the product, and city and the country of the company (including the state if in the USA), should be provided in parentheses.
For keywords, please see Medical Subject Headings (MeSH): https://meshb.nlm.nih.gov/MeSHonDemand.
All references, tables, and figures should be referred to within the main text, and they should be numbered consecutively in the order they are referred to within the main text. The symbols used must be nomenclature used standards.

Original Research Articles should be maximum of 4000 words and include subheadings below;

• Title (both in Turkish and English)
• Abstract (both in Turkish and English)
• Keywords (both in Turkish and English)
• Introduction
• Material and Methods
• Results
• Discussion
• Conclusions
• Figures and Tables Legend (if necessary)
• References

Case Reports should be maximum of 2000 words and include subheadings below;
• Title (both in Turkish and English)
• Abstract (both in Turkish and English)
• Keywords (both in Turkish and English)
• Introduction
• Case Presentation
• Discussion and Conclusion
• Figures and Tables Legend (if necessary)
• References

Literature Reviews should be maximum of 5000 words and include subheadings below;
• Title (both in Turkish and English)
• Abstract (both in Turkish and English)
• Keywords (both in Turkish and English)
• Main text
• Conclusion
• Figures and Tables Legend (if necessary)
• References

Letters to the editor should be maximum of 1000 words and should include subheadings below;
• Title
• Keywords
• Main text
• Figures and Tables Legend (if necessary)
• References

Preparation of the Figures and Tables

References

The references used in the article must be written in parenthesis at the end of the sentences.
References should be numbered in the order they appear in the text and placed at the end of the article.
References must contain surnames and initials of all authors, article title, name of the journal, the year, and the fırst and last page numbers.
Articles with 5 or more authors 'et al.' are mixed with the first three authors.
Abbreviations should be according to Index Medicus.
Authors must add the DOI (Digital object identifier) at the end of each reference.

For Examples;

Article in journal: 1. Tasci A, Tugcu V, Ozbay B, Mutlu B, Cicekler O. Stone formation in prostatic urethra after potassium-titanyl-phosphate laser ablation of the prostate for benign prostatic hyperplasia. J Endourol 2009;23:1879-81. https://doi.org/10.1089/end.2008.0596
For Books: 1.Günalp İ: Modern Üroloji. Ankara: Yargıçoğlu matbaası, 1975. Chapters in books: Anderson JL, Muhlestein JB. Extra corporeal ureteric stenting during laparoscopic pyeloplasty. Philadelphia: W.B. Saunders; 2003. p. 288-307
For website; Gaudin S. How moon landing changed technology history [Internet]. Computerworld UK. 2009 [cited 15 June 2014]. Available from: http://www.computerworlduk.com/in-depth/it-business/2387/how-moon-landing-changed-technology-history/
For conference proceeding; Proceedings of the Symposium on Robotics, Mechatronics and Animatronics in the Creative and Entertainment Industries and Arts. SSAISB 2005 Convention. University of Hertfordshire, Hatfield, UK; 2005.
For Thesis; Ercan S. Venöz yetmezlikli hastalarda kalf kası egzersizlerinin venöz fonksiyona ve kas gücüne etkisi. Suleyman Demirel University Faculty of Medicine Sports Medicine Department Thesis. Isparta: Suleyman Demirel University. 2016.

Manuscript Withdrawal & Reject
Withdrawal of the Article: Authors are required to submit a written application addressed to the Editor who has declared their withdrawal request and justification. They must wait for the Editor's response before submitting the manuscript to another journal.

Rejection: The manuscripts which are not accepted to be published are rejected with explanations.

AFTER ACCEPTANCE

If the manuscript is accepted, the acceptance letter is sent within two weeks, the last version of the manuscript is sent to the author for the last correspondence. The journal owner and the editorial board are authorized to decide which volume of the accepted article will be printed.
Authors may publish their articles on their personal or corporate websites by linking them to the appropriate cite and library rules.

Should you wish to request a change of author (name, author addition), we kindly ask that you submit this to the Editorial Board (publisher/journal address) with a letter signed by all authors before the evaluation process is completed. Unfortunately, we are unable to make any author changes after the article has been assigned to the issue and published.

Publication Ethics and Publication Malpractice Statement

Instructions for authors are shaped on the recommendations of the International Committee of Medical Journal Editors ( http://www.icmje.org/recommendations/ )
The Editorial Board Members of the Journal accept to follow 'Editorial Policy' of the 'Council of Science Editors' and the guidelines provided by the Committee on Publication Ethics (COPE) the International Committee of Medical Journal Editors (ICMJE) for dealing with scientific misconduct, such as falsification of data, plagiarism, improprieties of authorship, violation of generally accepted research practices and redundant publication and duplicate publication.
Originality, high scientific quality, and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. Manuscripts presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.
An approval of research protocols by the Ethics Committee following international agreements World Medical Association Declaration of Helsinki is required for experimental, clinical, and drug studies and some case reports. If required, an equivalent official document will be requested from the authors.
In studies requiring ethics committee approval, information about permission (name, date, and number of the board) should be included in the method section and on the article's first/last page.
If there is any concern or dispute over the stıdies, we will follow the Committee on Publication Ethics (COPE) flowcharts to solve them.

Every paper published in Endourology Bulletin is licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Endourology Bulletin does not charge any fees for the submission, evaluation, and publication of the articles.
Authors do not pay article processing fees for the studies they submit to the journal. All published articles can be accessed free of charge at “ https://endourolojibulteni.com/en/category/archive/ “.
All expenses of the journal are covered by the Endourology Society.